Medicare Enrolled
Dr. Ketan Doshi, M.D.
Hematology & Oncology · Ocala, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Doshi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Doshi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Doshi
Dr. Ketan Doshi is a hematology & oncology specialist in Ocala, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Doshi performed 133,084 Medicare services across 6,054 unique beneficiaries.
Between the years covered by Open Payments, Dr. Doshi received a total of $120,972 from 107 pharmaceutical and/or device companies across 1336 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Doshi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 4% volume in FL
$120,972 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 100579 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗133,084
Medicare services
Top 4% in FL for hematology & oncology
6,054
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,394 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
38,640 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 18,800 | $43 | $146 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
17,750 | $2 | $21 |
| Denosumab injection (Prolia/Xgeva) | 9,720 | $18 | $70 |
| Iron infusion (Monoferric) | 8,200 | $17 | $74 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
6,000 | $0 | $6 |
| Paclitaxel chemotherapy injection | 4,505 | $0 | $1 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
3,898 | $34 | $251 |
| Anti-nausea injection (aprepitant) | 3,120 | $1 | $9 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,449 | $8 | $35 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,305 | $8 | $19 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,631 | $10 | $62 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,600 | $0 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,444 | $0 | $1 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
1,373 | $6 | $30 |
| Injection, granisetron hydrochloride, 100 mcg | 1,260 | $0 | $25 |
| Anti-nausea injection (Aloxi/palonosetron) | 880 | $1 | $122 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
870 | $6 | $30 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
619 | $13 | $58 |
| Iron level test | 608 | $6 | $26 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
608 | $9 | $34 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
601 | $62 | $148 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
562 | $12 | $105 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
475 | $10 | $93 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
395 | $15 | $74 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
394 | $14 | $71 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
364 | $97 | $686 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
327 | $7 | $28 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
248 | $2 | $300 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
233 | $95 | $224 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
212 | $47 | $304 |
| Immunoassay substance measurement A laboratory test that uses immunoassay techniques to measure the level of a specific substance in a sample. |
172 | $17 | $181 |
| Nephelometry test A laboratory test that uses light scattering to measure the concentration of specific substances in a sample. |
172 | $13 | $176 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 169 | $20 | $124 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
154 | $64 | $157 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
138 | $1 | $7 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
110 | $1 | $6 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
104 | $16 | $97 |
| Platelet-associated immunoglobulin antibody test A laboratory test that identifies antibodies attached to platelets. It measures the amount of immunoglobulin associated with the patient's platelets. |
102 | $12 | $155 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
102 | $49 | $334 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
100 | $25 | $141 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
92 | $1 | $19 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
90 | $25 | $249 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
87 | $136 | $301 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
86 | $17 | $60 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
84 | $1 | $19 |
| Stool test for hidden blood (FIT) A laboratory test that analyzes a stool sample to detect hidden blood using an immunoassay method. |
83 | $16 | $70 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
72 | $22 | $156 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
67 | $21 | $152 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
62 | $16 | $78 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
61 | $67 | $214 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
60 | $56 | $205 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 60 | $408 | $638 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
60 | $2 | $19 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
56 | $1,203 | $4,120 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
53 | $1 | $9 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
50 | $104 | $297 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
48 | $9 | $63 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
47 | $42 | $281 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
44 | $10 | $73 |
| Adrenocorticotropic hormone (ACTH) level test A blood test that measures the amount of adrenocorticotropic hormone in your body. |
39 | $38 | $166 |
| PSA test (prostate cancer screening) | 39 | $18 | $91 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
36 | $120 | $343 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
35 | $17 | $111 |
| New patient office visit, complex (60-74 min) | 32 | $176 | $432 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
31 | $20 | $64 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
28 | $19 | $96 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
26 | $67 | $251 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
25 | $96 | $232 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $37 | $88 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
19 | $2 | $16 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
18 | $29 | $240 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
15 | $89 | $1,005 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
15 | $13 | $91 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
14 | $214 | $1,400 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
13 | $136 | $523 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.9% high complexity
80.1% medium
10.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$120,972
Total received (2018-2024)
Avg $17,282/year across 7 years
Top 8% in FL for hematology & oncology
107
Companies
1,336
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$86,474 (71.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,297 (18.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12,202 (10.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$15,123
2023
$11,304
2022
$23,637
2021
$13,460
2020
$15,954
2019
$22,330
2018
$19,165
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$14,328
Bayer HealthCare Pharmaceuticals Inc.
$10,785
GlaxoSmithKline, LLC.
$6,262
Novartis Pharmaceuticals Corporation
$5,965
Ipsen Biopharmaceuticals, Inc
$5,801
Celgene Corporation
$5,152
TESARO, Inc.
$4,849
BeiGene USA, Inc.
$4,418
Eisai Inc.
$4,286
Genentech USA, Inc.
$4,149
Agios Pharmaceuticals, Inc.
$3,995
Exelixis Inc.
$3,495
Gilead Sciences, Inc.
$3,233
Pharmacosmos Therapeutics Inc.
$2,896
Novocure Inc.
$2,657
AMAG Pharmaceuticals, Inc.
$2,640
Astellas Pharma US Inc
$2,553
E.R. Squibb & Sons, L.L.C.
$2,535
CTI BioPharma Corp.
$2,465
ARGENX US, INC.
$2,200
Incyte Corporation
$2,121
PFIZER INC.
$1,994
NOVARTIS PHARMACEUTICALS CORPORATION
$1,575
Heron Therapeutics, Inc.
$1,517
Taiho Oncology, Inc.
$1,470
Epizyme, Inc.
$1,391
EISAI INC.
$1,215
Janssen Biotech, Inc.
$1,169
Daiichi Sankyo Inc.
$919
Coherus Biosciences Inc.
$918
Amgen Inc.
$862
Lilly USA, LLC
$799
EMD Serono, Inc.
$660
Acceleron Pharma, Inc.
$650
Puma Biotechnology, Inc.
$648
Seagen Inc.
$630
Merck Sharp & Dohme LLC
$601
Merck Sharp & Dohme Corporation
$585
Takeda Pharmaceuticals U.S.A., Inc.
$486
Seattle Genetics, Inc.
$350
GENZYME CORPORATION
$323
Boehringer Ingelheim Pharmaceuticals, Inc.
$294
Pharmacyclics LLC, An AbbVie Company
$282
JAZZ PHARMACEUTICALS INC.
$277
Janssen Pharmaceuticals, Inc
$249
Clovis Oncology, Inc.
$220
Octapharma USA, Inc.
$209
ARRAY BIOPHARMA INC
$204
Kite Pharma, Inc.
$200
Pharmacyclics LLC, an AbbVie Company
$176
Regeneron Healthcare Solutions, Inc.
$172
Genmab U.S., Inc.
$161
Bayer Healthcare Pharmaceuticals Inc.
$153
Rigel Pharmaceuticals, Inc.
$152
Mirati Therapeutics, Inc.
$147
Stemline Therapeutics Inc.
$134
Kyowa Kirin, Inc.
$127
Stryker Corporation
$125
Janssen Scientific Affairs, LLC
$116
MorphoSys, US Inc.
$101
Alexion Pharmaceuticals, Inc.
$91
TerSera Therapeutics LLC
$90
ADC Therapeutics America, Inc.
$89
Lexicon Pharmaceuticals, Inc.
$80
Amneal Pharmaceuticals LLC
$74
Apellis Pharmaceuticals, Inc.
$74
Jazz Pharmaceuticals Inc.
$73
AVEO Pharmaceuticals, Inc.
$68
Epizyme, Inc.,
$67
TG THERAPEUTICS, INC.
$65
CSL Behring
$63
ABBVIE INC.
$59
G1 Therapeutics, Inc.
$59
Foundation Medicine, Inc.
$56
SOBI, INC
$51
Astellas Pharma Global Development
$48
SUN PHARMACEUTICAL INDUSTRIES INC.
$47
AcelRx Pharmaceuticals, Inc.
$45
Aveo Pharmaceuticals, Inc.
$45
SERVIER PHARMACEUTICALS LLC
$42
Servier Pharmaceuticals LLC
$42
Dova Pharmaceuticals
$38
Karyopharm Therapeutics Inc.
$38
Immunocore Limited
$36
TG Therapeutics, Inc.
$32
Horizon Therapeutics plc
$32
AbbVie, Inc.
$32
PharmaEssentia USA Corporation
$32
Secura Bio, Inc.
$30
ImmunoGen, Inc.
$29
MEDIVATION FIELD SOLUTIONS LLC
$27
Emmaus Medical, Inc.
$25
Alnylam Pharmaceuticals Inc.
$24
Tempus AI, Inc
$23
Sobi, Inc
$21
PUMA BIOTECHNOLOGY, INC.
$21
Menarini Silicon Biosystems, Inc.
$20
Medtronic, Inc.
$20
Array BioPharma Inc.
$18
GE HealthCare
$18
Sun Pharmaceutical Industries Inc.
$16
Blueprint Medicines Corporation
$14
SECURA BIO, INC.
$13
Dendreon Pharmaceuticals LLC
$12
AbbVie Inc.
$12
SANOFI-AVENTIS U.S. LLC
$11
Teva Pharmaceuticals USA, Inc.
$11
Top 3 companies account for 25.9% of total payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AUGTYRO · AVASTIN · AYVAKIT · Alecensa · Aliqopa · Aranesp · Avastin · BAVENCIO · BB-2121 · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CEREZYME · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Cellsearch · Cinvanti · Creon · DARZALEX · DOPTELET · DSUVIA · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMPRINT · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EXKIVITY · Elahere · Empaveli · Endari · Enhertu · Epkinly · Erleada · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Idelvion · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · KRYSTEXXA · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MAKO · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ODOMZO · OJJAARA · ONIVYDE · ONUREG · OPDIVO · OPDUALAG · Oncology · Onivyde · Optune · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PANZYGA · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Poteligeo · Prolia · Quzyttir · REBLOZYL · RETEVMO · REYATAZ · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rituxan · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SUSTOL · SUTENT · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tepmetko · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · VYVGART · VYXEOS · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (72%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 8% for hematology & oncology in FL.
Equivalent to $91 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
6
Per 100K population
1.5
County median income
$58,535
Nearest hospital
ADVENTHEALTH OCALA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Doshi is a mixed practice specialist, with above-average Medicare volume (top 4% in FL), with consulting-driven industry engagement in the top 8% of FL peers, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Doshi experienced with filgrastim injection (zarxio) for white blood cells?
Based on Medicare claims data, Dr. Doshi performed 38,640 filgrastim injection (zarxio) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Doshi receive payments from pharmaceutical companies?
Yes. Dr. Doshi received a total of $120,972 from 107 companies across 1,336 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Doshi's costs compare to other hematology & oncology specialists in Ocala?
Dr. Doshi's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Doshi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Ocala
Browse hematology & oncology specialists in Ocala ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology